BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31156955)

  • 1. EAHP statements survey 2016: sections 1, 3 and 4 of the European Statements of Hospital Pharmacy.
    Horák P; Gibbons N; Sýkora J; Batista A; Underhill J
    Eur J Hosp Pharm; 2017 Sep; 24(5):258-265. PubMed ID: 31156955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services.
    Amann S; Underhill J; Horák P; Batista A; Miljkovic N; Gibbons N
    Eur J Hosp Pharm; 2022 Jan; 29(1):26-32. PubMed ID: 34930791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAHP European Statements survey 2015.
    Horák P; Gibbons N; Sýkora J; Peppard J; Miharija Gala T; Underhill J
    Eur J Hosp Pharm; 2017 May; 24(3):138-146. PubMed ID: 31156925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAHP European Statements Survey 2017, focusing on sections 2 (Selection, Procurement and Distribution), 5 (Patient Safety and Quality Assurance) and 6 (Education and Research).
    Horák P; Underhill J; Batista A; Amann S; Gibbons N
    Eur J Hosp Pharm; 2018 Sep; 25(5):237-244. PubMed ID: 31157033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAHP European Statements baseline survey 2015: results.
    Horák P; Peppard J; Sýkora J; Miharija Gala T; Underhill J; Gibbons N
    Eur J Hosp Pharm; 2016 Mar; 23(2):69-75. PubMed ID: 31157794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EAHP European Statements baseline survey 2015: methodology.
    Underhill J; Gibbons N
    Eur J Hosp Pharm; 2016 Mar; 23(2):65-68. PubMed ID: 31162491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the hospital pharmacy profession in Europe.
    Kuruc Poje D; Fitzpatrick RW; Stevens C; Machin C; Underhill J; Horák P; Batista A; Süle A; Miljković N; Plesan C; Kohl S; Marzal Lopez G
    Eur J Hosp Pharm; 2024 Apr; ():. PubMed ID: 38604616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAHP European Statements baseline survey 2015: first steps on the implementation journey.
    Peppard J; Horák P; Gibbons N; Underhill J
    Eur J Hosp Pharm; 2016 Mar; 23(2):76-79. PubMed ID: 31156821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacy services in Germany: a national survey.
    Schulz C; Fischer A; Vogt W; Leichenberg K; Warnke U; Liekweg A; Georgi U; Langebrake C; Hoppe-Tichy T; Dörje F; Knoth H
    Eur J Hosp Pharm; 2021 Nov; 28(6):301-305. PubMed ID: 34697045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Trends in Hospital Pharmacy Practice in Lebanon.
    Chamoun N; Usta U; Karaoui LR; Salameh P; Hallit S; Shuhaiber P; Henaine AM; Akiki Y; Zeenny RM; Iskandar K
    Hosp Pharm; 2020 Apr; 55(2):112-118. PubMed ID: 32214445
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies.
    Leonardi Vinci D; Polidori P; Miljković N; Batista A; Amann S; Makridaki D; Kohl S
    Eur J Hosp Pharm; 2022 Sep; 29(5):242-247. PubMed ID: 34497129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.
    Penm J; Chaar B; Rose G; Moles R
    Res Social Adm Pharm; 2015; 11(1):63-73. PubMed ID: 25042568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements.
    Penm J; Chaar B; Moles R
    Int J Clin Pharm; 2015 Jun; 37(3):485-96. PubMed ID: 25733064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of intentions to monitor antihypertensive medication adherence in Irish community pharmacy: a factorial survey.
    Dillon P; McDowell R; Smith SM; Gallagher P; Cousins G
    BMC Fam Pract; 2019 Sep; 20(1):131. PubMed ID: 31519171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?
    Studer H; Boeni F; Messerli M; Hersberger KE; Lampert ML
    Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union.
    Atkinson J; Rombaut B
    Pharm Pract (Granada); 2011 Oct; 9(4):169-87. PubMed ID: 24198854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of EAHP's 2023 shortages survey.
    Miljković N; Polidori P; Leonardi Vinci D; Kuruc Poje D; Makridaki D; Kohl S; Süle A
    Eur J Hosp Pharm; 2024 Feb; ():. PubMed ID: 38307707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of hospital pharmacy practice in Namibia, based on FIP's Basel Statements.
    Bare A; Ivey M; Kibuule D; Stevenson JG
    Int J Pharm Pract; 2021 Aug; 29(4):350-355. PubMed ID: 33890674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.